Journal article 891 views 461 downloads
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations
J. W. Jukema,
M. Lettino,
P. Widimsky,
N. Danchin,
A. Bardaji,
J. A. Barrabes,
A. Cequier,
M. J. Claeys,
L. De Luca,
J. Dorler,
D. Erlinge,
P. Erne,
P. Goldstein,
S. M. Koul,
G. Lemesle,
T. F. Luscher,
C. M. Matter,
G. Montalescot,
D. Radovanovic,
J. Lopez Sendon,
P. Tousek,
F. Weidinger,
C. F. M. Weston,
A. Zaman,
U. Zeymer,
Clive Weston
European Heart Journal - Cardiovascular Pharmacotherapy, Volume: 1, Issue: 4, Pages: 232 - 244
Swansea University Author: Clive Weston
-
PDF | Accepted Manuscript
Download (631.12KB)
DOI (Published version): 10.1093/ehjcvp/pvv024
Abstract
Patient registries play an important role in cardiology. They provide data not found in randomised controlled trials, including valuable information on drug use and clinical outcomes. They allow an evaluation as to what extent guidelines are followed in practice.The Platelet Inhibition Registry in A...
Published in: | European Heart Journal - Cardiovascular Pharmacotherapy |
---|---|
Published: |
2015
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa21917 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2015-06-03T02:09:48Z |
---|---|
last_indexed |
2018-02-09T04:59:51Z |
id |
cronfa21917 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2016-04-11T14:50:00.8385287</datestamp><bib-version>v2</bib-version><id>21917</id><entry>2015-06-02</entry><title>Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations</title><swanseaauthors><author><sid>df85e4e0e139d0f46eb683174eba98a9</sid><ORCID>0000-0002-8995-8199</ORCID><firstname>Clive</firstname><surname>Weston</surname><name>Clive Weston</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2015-06-02</date><deptcode>PMSC</deptcode><abstract>Patient registries play an important role in cardiology. They provide data not found in randomised controlled trials, including valuable information on drug use and clinical outcomes. They allow an evaluation as to what extent guidelines are followed in practice.The Platelet Inhibition Registry in ACS EvalUation Study (PIRAEUS) project is an initiative of registry holders who manage national or international registries observing patients with acute coronary syndromes (ACS). The aim of PIRAEUS is to compare and combine available information/insights from various European ACS registries with a focus on P2Y12 inhibitors.The present publication introduces the 17 participating registries in narrative and tabular form.</abstract><type>Journal Article</type><journal>European Heart Journal - Cardiovascular Pharmacotherapy</journal><volume>1</volume><journalNumber>4</journalNumber><paginationStart>232</paginationStart><paginationEnd>244</paginationEnd><publisher/><keywords>acute coronary syndrome, antiplatelet treatment, myocardial infarction, disease registry</keywords><publishedDay>12</publishedDay><publishedMonth>5</publishedMonth><publishedYear>2015</publishedYear><publishedDate>2015-05-12</publishedDate><doi>10.1093/ehjcvp/pvv024</doi><url/><notes>Available online</notes><college>COLLEGE NANME</college><department>Medicine</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>PMSC</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2016-04-11T14:50:00.8385287</lastEdited><Created>2015-06-02T14:22:07.3353337</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>J. W.</firstname><surname>Jukema</surname><order>1</order></author><author><firstname>M.</firstname><surname>Lettino</surname><order>2</order></author><author><firstname>P.</firstname><surname>Widimsky</surname><order>3</order></author><author><firstname>N.</firstname><surname>Danchin</surname><order>4</order></author><author><firstname>A.</firstname><surname>Bardaji</surname><order>5</order></author><author><firstname>J. A.</firstname><surname>Barrabes</surname><order>6</order></author><author><firstname>A.</firstname><surname>Cequier</surname><order>7</order></author><author><firstname>M. J.</firstname><surname>Claeys</surname><order>8</order></author><author><firstname>L.</firstname><surname>De Luca</surname><order>9</order></author><author><firstname>J.</firstname><surname>Dorler</surname><order>10</order></author><author><firstname>D.</firstname><surname>Erlinge</surname><order>11</order></author><author><firstname>P.</firstname><surname>Erne</surname><order>12</order></author><author><firstname>P.</firstname><surname>Goldstein</surname><order>13</order></author><author><firstname>S. M.</firstname><surname>Koul</surname><order>14</order></author><author><firstname>G.</firstname><surname>Lemesle</surname><order>15</order></author><author><firstname>T. F.</firstname><surname>Luscher</surname><order>16</order></author><author><firstname>C. M.</firstname><surname>Matter</surname><order>17</order></author><author><firstname>G.</firstname><surname>Montalescot</surname><order>18</order></author><author><firstname>D.</firstname><surname>Radovanovic</surname><order>19</order></author><author><firstname>J.</firstname><surname>Lopez Sendon</surname><order>20</order></author><author><firstname>P.</firstname><surname>Tousek</surname><order>21</order></author><author><firstname>F.</firstname><surname>Weidinger</surname><order>22</order></author><author><firstname>C. F. M.</firstname><surname>Weston</surname><order>23</order></author><author><firstname>A.</firstname><surname>Zaman</surname><order>24</order></author><author><firstname>U.</firstname><surname>Zeymer</surname><order>25</order></author><author><firstname>Clive</firstname><surname>Weston</surname><orcid>0000-0002-8995-8199</orcid><order>26</order></author></authors><documents><document><filename>0021917-05032016121525.pdf</filename><originalFilename>PIREAUS.pdf</originalFilename><uploaded>2016-03-05T12:15:25.8530000</uploaded><type>Output</type><contentLength>690707</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2016-05-12T00:00:00.0000000</embargoDate><copyrightCorrect>true</copyrightCorrect></document></documents><OutputDurs/></rfc1807> |
spelling |
2016-04-11T14:50:00.8385287 v2 21917 2015-06-02 Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations df85e4e0e139d0f46eb683174eba98a9 0000-0002-8995-8199 Clive Weston Clive Weston true false 2015-06-02 PMSC Patient registries play an important role in cardiology. They provide data not found in randomised controlled trials, including valuable information on drug use and clinical outcomes. They allow an evaluation as to what extent guidelines are followed in practice.The Platelet Inhibition Registry in ACS EvalUation Study (PIRAEUS) project is an initiative of registry holders who manage national or international registries observing patients with acute coronary syndromes (ACS). The aim of PIRAEUS is to compare and combine available information/insights from various European ACS registries with a focus on P2Y12 inhibitors.The present publication introduces the 17 participating registries in narrative and tabular form. Journal Article European Heart Journal - Cardiovascular Pharmacotherapy 1 4 232 244 acute coronary syndrome, antiplatelet treatment, myocardial infarction, disease registry 12 5 2015 2015-05-12 10.1093/ehjcvp/pvv024 Available online COLLEGE NANME Medicine COLLEGE CODE PMSC Swansea University 2016-04-11T14:50:00.8385287 2015-06-02T14:22:07.3353337 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine J. W. Jukema 1 M. Lettino 2 P. Widimsky 3 N. Danchin 4 A. Bardaji 5 J. A. Barrabes 6 A. Cequier 7 M. J. Claeys 8 L. De Luca 9 J. Dorler 10 D. Erlinge 11 P. Erne 12 P. Goldstein 13 S. M. Koul 14 G. Lemesle 15 T. F. Luscher 16 C. M. Matter 17 G. Montalescot 18 D. Radovanovic 19 J. Lopez Sendon 20 P. Tousek 21 F. Weidinger 22 C. F. M. Weston 23 A. Zaman 24 U. Zeymer 25 Clive Weston 0000-0002-8995-8199 26 0021917-05032016121525.pdf PIREAUS.pdf 2016-03-05T12:15:25.8530000 Output 690707 application/pdf Accepted Manuscript true 2016-05-12T00:00:00.0000000 true |
title |
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations |
spellingShingle |
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations Clive Weston |
title_short |
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations |
title_full |
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations |
title_fullStr |
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations |
title_full_unstemmed |
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations |
title_sort |
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations |
author_id_str_mv |
df85e4e0e139d0f46eb683174eba98a9 |
author_id_fullname_str_mv |
df85e4e0e139d0f46eb683174eba98a9_***_Clive Weston |
author |
Clive Weston |
author2 |
J. W. Jukema M. Lettino P. Widimsky N. Danchin A. Bardaji J. A. Barrabes A. Cequier M. J. Claeys L. De Luca J. Dorler D. Erlinge P. Erne P. Goldstein S. M. Koul G. Lemesle T. F. Luscher C. M. Matter G. Montalescot D. Radovanovic J. Lopez Sendon P. Tousek F. Weidinger C. F. M. Weston A. Zaman U. Zeymer Clive Weston |
format |
Journal article |
container_title |
European Heart Journal - Cardiovascular Pharmacotherapy |
container_volume |
1 |
container_issue |
4 |
container_start_page |
232 |
publishDate |
2015 |
institution |
Swansea University |
doi_str_mv |
10.1093/ehjcvp/pvv024 |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
1 |
active_str |
0 |
description |
Patient registries play an important role in cardiology. They provide data not found in randomised controlled trials, including valuable information on drug use and clinical outcomes. They allow an evaluation as to what extent guidelines are followed in practice.The Platelet Inhibition Registry in ACS EvalUation Study (PIRAEUS) project is an initiative of registry holders who manage national or international registries observing patients with acute coronary syndromes (ACS). The aim of PIRAEUS is to compare and combine available information/insights from various European ACS registries with a focus on P2Y12 inhibitors.The present publication introduces the 17 participating registries in narrative and tabular form. |
published_date |
2015-05-12T03:26:03Z |
_version_ |
1763750930713411584 |
score |
11.036706 |